Bucindolol

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Bucindolol
Bucindolol.png
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
ECHA InfoCard 100.114.291
Chemical and physical data
Formula C22H25N3O2
Molar mass 363.45 g/mol

Bucindolol is a non-selective beta blocker with additional weak alpha-blocking properties and some intrinsic sympathomimetic activity.[1][2] It was under review by the FDA in the United States for the treatment of heart failure in 2009, but was rejected due to issues pertaining to integrity of data submitted.[1][3]

See also[edit]

References[edit]